Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

492
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
492
Role of Cerebellum and Prefrontal Cortex in Memory01:14

Role of Cerebellum and Prefrontal Cortex in Memory

953
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
953

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gold-containing compounds target an apicomplexan Thioredoxin reductase: Disclosing reactivity through structural and functional characterization.

International journal of biological macromolecules·2026
Same author

Mitochondrial dysfunction and oxidative stress in autism spectrum disorder: pharmacological insights into natural antioxidants.

Frontiers in pharmacology·2026
Same author

Hypertension and brain damage: evidence from rodent models.

Laboratory animal research·2026
Same author

Adjacent domains drive the emergence of misfolded intermediates in the folding pathway of the PDZ4 from MAGI1.

BBA advances·2026
Same author

Conformational selection and linker-dependent specificity in the MAGI-1 WW tandem.

International journal of biological macromolecules·2026
Same author

Mitochondria-Associated MicroRNAs: Emerging Roles in the Pathogenesis of Parkinson's Disease.

Biomedicines·2026

Related Experiment Video

Updated: Jan 5, 2026

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.5K

PPARγ and Cognitive Performance.

Michele d'Angelo1, Vanessa Castelli1, Mariano Catanesi1

  • 1Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

International Journal of Molecular Sciences
|October 17, 2019
PubMed
Summary
This summary is machine-generated.

Peroxisome proliferator-activated receptor gamma (PPARγ) agonists show neuroprotective effects, aiding synaptic plasticity and neurite outgrowth. This review discusses research on PPARγ ligands for improving cognitive performance in various diseases.

Keywords:
Alzheimer’s diseaseHuntingtonPPAR gammaPPARγ agonistsParkinson’s diseaseautismschizophrenia

More Related Videos

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.7K
Barnes Maze Testing Strategies with Small and Large Rodent Models
12:59

Barnes Maze Testing Strategies with Small and Large Rodent Models

Published on: February 26, 2014

43.3K

Related Experiment Videos

Last Updated: Jan 5, 2026

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.5K
Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
06:46

Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage

Published on: August 4, 2018

12.7K
Barnes Maze Testing Strategies with Small and Large Rodent Models
12:59

Barnes Maze Testing Strategies with Small and Large Rodent Models

Published on: February 26, 2014

43.3K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Nuclear receptors play a role in various human conditions, including neurodegenerative diseases and cognitive decline.
  • Peroxisome proliferator-activated receptor gamma (PPARγ) has emerged as a key player in neuroprotection.
  • PPARγ agonists demonstrate potential in supporting neuronal health.

Purpose of the Study:

  • To review the current research on the neuroprotective roles of PPARγ agonists.
  • To discuss the therapeutic potential of PPARγ ligands in improving cognitive function.
  • To explore the link between nuclear receptors and neurodegenerative conditions.

Main Methods:

  • Literature review of preclinical and clinical studies.
  • Analysis of research on PPARγ signaling pathways.
  • Synthesis of findings on PPARγ ligands and their effects on synaptic plasticity and neurite outgrowth.

Main Results:

  • PPARγ agonists exhibit neuroprotective properties.
  • These agents support crucial neuronal functions like synaptic plasticity and neurite outgrowth.
  • Evidence suggests PPARγ ligands can improve cognitive performance in pathological models.

Conclusions:

  • PPARγ agonists represent a promising therapeutic strategy for neurodegenerative diseases.
  • Targeting PPARγ may offer a novel approach to enhance cognitive function.
  • Further research into PPARγ ligands is warranted for clinical application.